Page 29 - Lupin

Stocks drop for second day as Lupin falls most since '08

Stocks fell for a second day in volatile trading, as drugmakers countered advances in automakers before the expiry of the monthly derivatives series on Thursday

Lupin gets three observations from USFDA for Mandideep plant

Audit was conducted at Mandideep location; observations received are minor in nature and will not lead to disruption of product supply

Nifty Pharma index hits 52-week low; Lupin at 18-month low

At 10:43 AM, the Nifty Pharma index was down 4% as compared to a marginal 0.14% decline in the Nifty 50 index

Lupin dips on USFDA observations on Goa facility

The stock dipped 7% to Rs 1,736 on the BSE in intra-day trade.

Lupin completes $880-mn Gavis purchase

US business contributes around 45% of Lupin's revenue.